Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |